These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6467271)

  • 41. QT-interval turbulence induced by atrial and ventricular extrastimuli in patients with ventricular tachycardia.
    Savelieva I; Wichterle D; Camm JA
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S187-92. PubMed ID: 15683493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ventricular tachyarrhythmia initiation in a canine model of recent myocardial infarction. Comparison of unipolar cathodal, anodal and bipolar stimulation.
    Ohm OJ; Mitamura H; Michelson EL; Sauermelch C; Dreifus LS
    Cardiology; 1987; 74(3):169-81. PubMed ID: 3594506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial and ventricular activation sequence after ventricular induction/entrainment pacing during fast-slow atrioventricular nodal reentrant tachycardia: New insight into the use of V-A-A-V for the differential diagnosis of supraventricular tachycardia.
    Kaneko Y; Nakajima T; Irie T; Iizuka T; Tamura S; Kurabayashi M
    Heart Rhythm; 2017 Nov; 14(11):1615-1622. PubMed ID: 28606635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Torsade de pointes ventricular tachycardia].
    Mikhaĭlov P
    Vutr Boles; 1984; 23(5):72-7. PubMed ID: 6084362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
    Uvelin A; Pejaković J; Mijatović V
    J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanisms.
    Becker R; Klinkott R; Bauer A; Senges JC; Schreiner KD; Voss F; Kuebler W; Schoels W
    J Am Coll Cardiol; 2000 Jun; 35(7):1939-46. PubMed ID: 10841247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Torsade de pointe. Report of 18 cases.
    Chalak W; Taha A; Araoya M; Rifaat M
    J Med Liban; 1993; 41(2):62-8; discussion 68-9. PubMed ID: 8057345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
    Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S
    Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quinidine-induced torsade de pointes suppressed by paroxysmal atrial fibrillation.
    Maisuls E; Lorber A
    Int J Cardiol; 1987 Sep; 16(3):315-7. PubMed ID: 3654030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed repolarization syndrome.
    Schweitzer P; Mark H
    Am J Med; 1983 Sep; 75(3):393-401. PubMed ID: 6614027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mechanism of torsades de pointes in a canine model.
    Bardy GH; Ungerleider RM; Smith WM; Ideker RE
    Circulation; 1983 Jan; 67(1):52-9. PubMed ID: 6847804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Induction of ventricular tachycardia by esophageal stimulation. Apropos of 2 cases].
    Kieny JR; Roul G; Sachs D; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1587-90. PubMed ID: 1763925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventricular tachyarrhythmias in the long QT syndromes.
    Jackman WM; Clark M; Friday KJ; Aliot EM; Anderson J; Lazzara R
    Med Clin North Am; 1984 Sep; 68(5):1079-109. PubMed ID: 6149338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shortening of the QT interval of the EKG is associated primarily with increased ventricular contractility rather than heart rate.
    Huang MH; Wolf SG; Armour JA
    Integr Physiol Behav Sci; 1995; 30(1):5-11. PubMed ID: 7794786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinidine-induced long QTU interval and torsade de pointes: role of bradycardia-dependent early afterdepolarizations.
    el-Sherif N; Bekheit SS; Henkin R
    J Am Coll Cardiol; 1989 Jul; 14(1):252-7. PubMed ID: 2738268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.